The pharmacodynamic model developed for children with heart failure could be used in conjunction with the existing population pharmacokinetic model for enalapril and enalaprilat to simulate the effect of a given dose of enalapril on the angiotensin II/angiotensin I ratio. Here, AGT is linked to heart failure.